Neuronetics ROA 2017-2024 | STIM
Neuronetics ROA - Return on Assets Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Total Assets | Return on Assets |
2024-12-31 | $-0.04B | $0.14B | -42.31% |
2024-09-30 | $-0.04B | $0.07B | -36.83% |
2024-06-30 | $-0.03B | $0.10B | -31.22% |
2024-03-31 | $-0.03B | $0.10B | -26.15% |
2023-12-31 | $-0.03B | $0.12B | -29.06% |
2023-09-30 | $-0.03B | $0.09B | -31.88% |
2023-06-30 | $-0.03B | $0.10B | -29.09% |
2023-03-31 | $-0.04B | $0.10B | -31.97% |
2022-12-31 | $-0.04B | $0.12B | -30.27% |
2022-09-30 | $-0.04B | $0.12B | -28.85% |
2022-06-30 | $-0.04B | $0.12B | -27.56% |
2022-03-31 | $-0.04B | $0.13B | -24.91% |
2021-12-31 | $-0.03B | $0.14B | -21.92% |
2021-09-30 | $-0.03B | $0.14B | -21.46% |
2021-06-30 | $-0.02B | $0.15B | -20.13% |
2021-03-31 | $-0.02B | $0.15B | -23.65% |
2020-12-31 | $-0.03B | $0.08B | -34.46% |
2020-09-30 | $-0.03B | $0.08B | -36.99% |
2020-06-30 | $-0.04B | $0.08B | -38.61% |
2020-03-31 | $-0.04B | $0.09B | -34.83% |
2019-12-31 | $-0.03B | $0.10B | -28.10% |
2019-09-30 | $-0.03B | $0.11B | -25.23% |
2019-06-30 | $-0.03B | $0.11B | -22.71% |
2019-03-31 | $-0.03B | $0.11B | -27.59% |
2018-12-31 | $-0.02B | $0.12B | -34.85% |
2018-06-30 | $-0.02B | $0.03B | -228.57% |
2018-03-31 | $-0.01B | $0.00B | 0.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | MED INSTRUMENTS | $0.301B | $0.075B |
Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics, Inc. is based in Malvern, United States. |